Overview

Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients

Status:
Recruiting
Trial end date:
2022-01-10
Target enrollment:
Participant gender:
Summary
Title: Effect of n-acetylcysteine as add-on therapy with Selective Serotonin Reuptake Inhibitors in moderate to severe Obsessive Compulsive Disorder patients. Purpose of the study: To assess the effects of the addition of n-acetylcysteine with SSRIs on the severity of symptoms in obsessive-compulsive disorder patients.
Phase:
N/A
Details
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Treatments:
Acetylcysteine
N-monoacetylcystine